Elongation factor-2 kinase: New archetype of protein kinase

被引：0
作者：
Ryazanov, AG
Pavur, KS
Dorovkov, MV
Li, YC
Mendola, CE
Hait, WN
机构：
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst NJ, Piscataway, NJ 08854 USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2945
引用
收藏
页码：A1360 / A1360
页数：1
相关论文
共 50 条
[41]   Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target [J].
Karakas, Didem ;
Ozpolat, Bulent .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (06) :775-787
[42]   Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells [J].
Ahmed A. Ashour ;
Abdel-Aziz H. Abdel-Aziz ;
Ahmed M. Mansour ;
S. Neslihan Alpay ;
Longfei Huo ;
Bulent Ozpolat .
Apoptosis, 2014, 19 :241-258
[43]   Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells [J].
Ashour, Ahmed A. ;
Abdel-Aziz, Abdel-Aziz H. ;
Mansour, Ahmed M. ;
Alpay, S. Neslihan ;
Huo, Longfei ;
Ozpolat, Bulent .
APOPTOSIS, 2014, 19 (01) :241-258
[44]   Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target [J].
Didem Karakas ;
Bulent Ozpolat .
Journal of Molecular Medicine, 2020, 98 :775-787
[45]   Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8+ T cells [J].
Das, Jugal Kishore ;
Ren, Yijie ;
Kumar, Anil ;
Peng, Hao-Yun ;
Wang, Liqing ;
Xiong, Xiaofang ;
Alaniz, Robert C. ;
de Figueiredo, Paul ;
Ren, Xingcong ;
Liu, Xiaoqi ;
Ryazonov, Alexey G. ;
Yang, Jin-Ming ;
Song, Jianxun .
SCIENCE ADVANCES, 2022, 8 (05)
[46]   LC/MS/MS assay and mouse pharmacokinetics of the eukaryotic elongation factor-2 kinase inhibitor NSC 745343 [J].
Reid, Joel ;
McGovern, Renee ;
Buhrow, Sarah ;
Jia, Lee ;
Ames, Matthew .
CANCER RESEARCH, 2009, 69
[47]   Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3 [J].
Karyo, Racheli ;
Eskira, Yael ;
Pinhasov, Albert ;
Belmaker, R. H. ;
Agam, Galila ;
Eldar-Finkelman, Hagit .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2010, 45 (04) :449-455
[48]   Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase [J].
Cho, SI ;
Koketsu, I ;
Ishihara, H ;
Matsushita, M ;
Nairn, AC ;
Fukazawa, H ;
Uehara, Y .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1475 (03) :207-215
[49]   Cytoprotective Effect of the Elongation Factor-2 Kinase-Mediated Autophagy in Breast Cancer Cells Subjected to Growth Factor Inhibition [J].
Cheng, Yan ;
Li, Huaijun ;
Ren, Xingcong ;
Niu, Tingkuang ;
Hait, William N. ;
Yang, Jinming .
PLOS ONE, 2010, 5 (03)
[50]   Identification of Toxoplasma calcium-dependent protein kinase 3 as a stress-activated elongation factor 2 kinase [J].
Lis, Agnieszka ;
Baptista, Carlos Gustavo ;
Dahlgren, Kelsey ;
Corvi, Maria M. ;
Blader, Ira J. .
MSPHERE, 2023, 8 (04)
12345